New hope for cancer patients: MedUni Vienna starts 24 million program!
New hope for cancer patients: MedUni Vienna starts 24 million program!
Wien, Österreich - On July 7, 2025, a new funding program of the Ludwig Boltzmann Gesellschaft (LBG) was presented in Vienna, which focuses on patient: internal-oriented topics in non-commercial clinical research. This program, known as clinical research groups (KFG), was launched in 2022 to close an important gap in the field of clinical research. The funding amount of a total of 24 million euros is provided by the Federal Ministry of Women, Science and Research (BMFWF) and the Fund Future Austria.
The event illuminated the three new clinical research groups that focus on oncology and neurology. These KFGs are:
-
crc-res
- Goal: Combating therapy resistance in colon cancer with personalized tumor models.
- Head: Johannes Längle from the University Clinic for General Surgery, MedUni Vienna.
-
Strikebc
- goal: improvement of the chances of survival and quality of life of people with bladder cancer.
- Head: Bernhard Englinger from the University Clinic for Urology, MedUni Vienna.
- epiconn
- goal: foresight and personalized treatment for focal epilepsy.
- Head: Silvia Bonelli-Nauer from the University Clinic for Neurology, MedUni Vienna.
The KFGs are funded for up to eight years, each with up to around eight million euros. Personalized tumor models are used in the KFG CRC-Res to identify new therapeutic approaches. StrikeBC will collect relevant data from various sources to develop individual treatment options for bladder cancer. In addition, Epiconn will identify biomarkers in order to individualize the treatment of focal epilepsy and to improve the quality of life of those affected sustainably. In the first phase of Epiconn, 300 people with focal epilepsy are to be invited to participate.
research funding in translational medicine
The importance of clinical research groups extends beyond the pure funding. The aim of the funding is to intensify the scientific cooperation between basic research and clinical application and thus also support translational research processes. Translational medicine deals with the implementation of research results into health care and requires close cooperation between different disciplines.
The basics of translational medicine are exciting: Studies show that only a small part of new concepts of health research finds a direct appearance into clinical practice. This is where the KFG initiative comes into play, which promotes the exchange of knowledge between researchers, therapists and patients and focuses on improving health promotion, diagnosis and therapy, in line with the knowledge of the knowledge translation.
long -term perspectives
The promotion of such research groups is not only dependent on monetary support, but also on the creation of structured training and cooperation opportunities within the clinics. The aim is to create a solid basis for clinical research and to familiarize the institutes intensively with the challenges and needs in patient care.
With the new funding program of the Ludwig Boltzmann Society and the three new clinical research groups, Vienna takes another step towards improved health care and shows how medical research and clinical practice can go hand in hand. The high financial support and focus on patient: internal -oriented topics can be seen as an example of promising medical research that wants to meet the high demands in healthcare.
| Details | |
|---|---|
| Ort | Wien, Österreich |
| Quellen | |
Kommentare (0)